Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Empowering Older Antibiotics
Journal article

Empowering Older Antibiotics

Abstract

Avycaz combines an older cephalosporin antibiotic, ceftazidime, and the β-lactamase inhibitor avibactam. Ceftazidime targets penicillin-binding proteins (PBPs) in the bacterial periplasm that are required for cell wall synthesis. Avibactam blocks β-lactamases (β-L) in the periplasm, which would otherwise inactivate the antibiotics resulting in drug resistance.

Authors

Wright GD

Journal

Cell, Vol. 167, No. 2,

Publisher

Elsevier

Publication Date

October 2016

DOI

10.1016/j.cell.2016.09.032

ISSN

0092-8674